NAS:MLTX (Switzerland)  
MoonLake Immunotherapeutics logo

MoonLake Immunotherapeutics

$ 8.62 +0.07 (+0.82%) 04:00 PM EST
P/E:
N/A
P/B:
0
Market Cap:
$ 319.42M
Enterprise V:
$ 322.75M
Volume:
119.57K
Avg Vol (2M):
54.80K
Volume:
119.57K
Market Cap $:
319.42M
PE Ratio:
N/A
Avg Vol (2-Month):
54.80K
Enterprise Value $:
322.75M
PB Ratio:
0
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

MoonLake Immunotherapeutics
NAICS : 541720 SIC : 2833
Dorfstrasse 29, Zug, CHE, 6300
Description
MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases. The company focuses on developing its novel tri-specific Nanobody Sonelokimab (SLK), an IL-17A and IL-17F inhibitor, in multiple inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.
Name Current Vs Industry Vs History
Interest Coverage No Debt
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 88.97
9-Day RSI 76.28
14-Day RSI 68.88

Liquidity Ratio

Name Current Vs Industry Vs History

Dividend & Buy Back

Name Current Vs Industry Vs History
Name Current Vs Industry Vs History

GF Value Rank

Name Current Vs Industry Vs History
PE Ratio N/A
N/A
N/A
PE Ratio without NRI N/A
N/A
N/A

Financials (Next Earnings Date:2022-11-30 Est.)

MLTX's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:MLTX

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) 0
Beta 0
Volatility % 0
14-Day RSI 68.88
14-Day ATR ($) 0.832484
20-Day SMA ($) 6.642
12-1 Month Momentum % 0
52-Week Range ($) 4.25 - 15
Shares Outstanding (Mil) 36.93

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

MoonLake Immunotherapeutics Filings

Document Form Filing Date
No Filing Data

Headlines

See More